Things
Cascading call announced by the University of Modena and Reggio Emilia – Spoke 1 “Genetic Diseases” in compliance with the provisions of the art. 5 of Public Notice no. 3138 of 12/16/2021, as part of the PNRR funding - Mission 4, Component 2 "From research to business", Investment 1.4 "Strengthening research structures and creation of R&D "national champions", relating to the identified project with code CN00000041, entitled “National Center for Gene Therapy and Drugs based on RNA Technology”.
Who is it aimed at?
– Public research bodies and institutions, including universities, and the bodies referred to in Legislative Decree no. 218/2016 (https://www.mur.gov.it/it/aree-tematiche/ricerca/il-sistema-della-ricerca/enti-di-ricerca-pubblici); - Scientific Hospitalization and Care Institutes – IRCCS, whether public or private in nature; - Research Organizations registered in the National Research Registry (ANR)
What does it predict
Through this call we intend to support research activities in the following areas: Track for Line of intervention A: Track A - Research Activities (RF, RI) Areas of development of the Spoke A1 - Bioenergetic profile in multiple tissues of mitochondrial disease models treated with gene and RNA therapy – A2- Circadian profile of the bioenergetic response to gene and RNA therapy in models of mitochondrial diseases.
